为期两周的等待及其他改善癌症诊断的举措：其是否改变了生存率？答案尚不清楚——证据太过薄弱。

The 2-week wait and other initiatives to improve cancer diagnosis: Has it altered survival? The answer is unclear-the evidence is too weak.

作者信息

Bankhead C

机构信息

Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.

出版信息

Eur J Cancer Care (Engl). 2017 May;26(3). doi: 10.1111/ecc.12712. Epub 2017 May 10.

DOI:10.1111/ecc.12712

PMID:28488745

Abstract

The UK is one of the lowest ranked high-income countries for cancer survival. Later stage at diagnosis is a significant contributor to reduced survival. Several strategies have been introduced to reduce delays in an effort to diagnose cancer earlier. This commentary summarises the evidence and impact of these initiatives.

摘要

在癌症生存率方面，英国在高收入国家中排名靠后。确诊时处于较晚阶段是生存率降低的一个重要因素。为减少延误以便更早诊断癌症，已采取了多项策略。本评论总结了这些举措的证据和影响。